Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2021 | OncoMyx Therapeutics | $50.0M Series B | B Capital Group, Benjamin Rovinski, Ph.D. | Boehringer Ingelheim, City Hill Ventures, Delos Capital, Korea Investment Partners, LYZZ Capital, Xeraya Capital |
| Jun 5, 2019 | OncoMyx Therapeutics | $25.0M Series A | Kanad Das, Tim Xiao, Jason Rushton | City Hill Ventures, Korea Investment Partners |